2023 in review, and a look at biotech in 2024

In the last episode of “The Readout LOUD,” STAT’s biotech podcast, the hosts reflect on the biggest stories of 2023, discuss the best and worst CEOs in the industry, and make predictions for the drug industry in 2024. They also question what it means to be a bad CEO, whether biotech can withstand another election year, and if it’s possible to attend too many J.P. Morgan parties. The episode covers more on the year’s best and worst CEOs, biotech in 2024, and offers ways to subscribe to related podcasts and newsletters. They also invite feedback from listeners via email.

Source link